Screener
Neurocrine Biosciences NBIX Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
| (in millions, except per share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 1,498.8 | 1,378.4 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 220.0 shares authorized; 100.6 and 100.1 shares issued and outstanding, respectively | 0.1 | 0.1 |
| Additional paid-in capital | 2,817.3 | 2,792.2 |
| Accumulated other comprehensive income | 0.4 | 13.1 |
| Retained earnings | 589.6 | 447.7 |
| Total stockholders’ equity | 3,407.4 | 3,253.1 |
Item 1. Financial Statements
FAQ
- What is Neurocrine Biosciences's common stock par value per share?
- Neurocrine Biosciences (NBIX) reported common stock par value per share of $0.00 in Q1 2026.
- How has Neurocrine Biosciences's common stock par value per share changed year-over-year?
- Neurocrine Biosciences's common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Neurocrine Biosciences's common stock par value per share?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Neurocrine Biosciences's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude